Substance use & recovery

What Utilization Review and Peer-to-Peer Calls Are

Utilization review is how an insurer decides whether to authorize rehab, for how long, and at what level of care. When it moves toward a denial, a peer-to-peer call lets your clinician make the case directly to the insurer's reviewing physician. This explains prior authorization, concurrent review, what happens on a peer-to-peer, and how parity law limits what an insurer's review is allowed to do.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is a peer-to-peer review?

A peer-to-peer review — sometimes called a doctor-to-doctor reconsideration — is a phone conversation between your treating clinician and a physician employed or contracted by your insurer to decide whether a specific treatment is medically necessary. The insurer's physician is often called the medical director or a peer reviewer. The word "peer" means a fellow doctor, not someone who has met you; they are reviewing your case against the plan's criteria.

A peer-to-peer review is the point where the clinician who knows your case speaks directly to the insurer's reviewer instead of trading letters. It usually happens when a request for care is heading toward denial, or right after a denial, and it is frequently the fastest way to reverse one. Because it is a live clinical conversation, the detail your clinician can supply on the call often matters more than anything on the original form.

What utilization review is

Utilization review is the insurer's process for deciding whether care is necessary, appropriate, and at the right level — before, during, and after it is delivered. It is also called utilization management, and the peer-to-peer call is one tool inside it. Every authorization, every check on whether a rehab stay should continue, and every denial runs through this machinery. It exists to control spending, and it applies to substance-use care intensively.

The process usually has three moments. Prior authorization is approval sought before care begins. Concurrent review happens during a stay, checking whether continued care is still justified. Retrospective review looks back after the fact. Before any of this, a program often runs a verification of benefits to learn what your plan actually covers. Knowing which stage you are in tells you what is being decided and what your options are at that moment.

Prior authorization, concurrent review, and getting cut short

The stage that surprises people most is concurrent review, because it can end care that was already approved. A plan may authorize a few days at a level of care, then reassess and decide further days are not justified — cutting a stay short mid-treatment. Prior authorization decides whether you get in; concurrent review decides whether you stay. Both are where a peer-to-peer call most often comes into play.

When an insurer signals it will not authorize more days, that is a concurrent review heading toward denial, and it triggers rights. You can request the peer-to-peer, ask for the specific criteria being applied, and, if the denial stands, move to a formal appeal. An insurer cutting a stay short is not the final word; it is the start of a process. The clinician's job on the call is to show, against the plan's own criteria, why the current level of care is still necessary.

What happens on a peer-to-peer call?

On a peer-to-peer, your treating clinician presents the clinical case directly to the insurer's reviewing physician and answers questions about why the requested care meets medical-necessity criteria. These calls are often short and scheduled on tight windows, sometimes offered only for a same-day or next-day slot, so being ready matters. The treating clinician, not the patient, makes the case.

What helps the call succeed is specificity: the assessment findings, what lower levels of care were tried or why they would be unsafe, any co-occurring conditions, and the risk of stepping down too soon. The reviewer is matching the case to the plan's criteria, so the clinician's argument lands best when it speaks in those terms. If the peer-to-peer does not resolve it, the denial becomes formal and the written appeal process begins — the call is simply a faster, earlier chance to fix it first.

How parity law limits utilization review

Utilization review is not unlimited, and parity law is the main check on it. The Mental Health Parity and Addiction Equity Act generally requires a plan that covers mental-health and substance-use benefits to apply no more restrictive treatment limits to them than it applies to comparable medical and surgical care 1Ref 1Centers for Medicare & Medicaid Services (2024).Mental Health Parity and Addiction Equity Act (MHPAEA).Used for the claim that MHPAEA generally bars plans covering mental-health/substance-use benefits from imposing more restrictive treatment limits — including utilization-management rules like prior authorization and concurrent review — than for comparable medical care.. Utilization-management rules — prior authorization, concurrent review, how often reviews are demanded — are treatment limits, so a plan is not supposed to review SUD care more harshly than it reviews similar medical care.

The same principle reaches into public coverage: parity requirements apply within Medicaid and CHIP for mental-health and substance-use benefits as well 2Ref 2Centers for Medicare & Medicaid Services / Medicaid.gov (2024).Parity — Behavioral Health Services.Used for the claim that parity requirements apply within Medicaid and CHIP for mental-health and substance-use benefits, extending the same principle to public coverage.. That gives a concrete argument when an insurer's review feels lopsided — for instance, if it demands repeated concurrent reviews for addiction care but authorizes a comparable medical admission with far less scrutiny. If a plan reviews addiction care more strictly than comparable medical care, that disparity is itself a parity problem worth raising.

What the review is checking against

Utilization review is not arbitrary; it measures your case against level-of-care criteria. Quality addiction treatment spans levels of intensity — outpatient, intensive outpatient, residential, inpatient — chosen by an assessment of what a person needs, and behavioral therapy, medication, and mutual-help support are all evidence-based options 3Ref 3National Institute on Alcohol Abuse and Alcoholism (2024).Types of Alcohol Treatment — Alcohol Treatment Navigator.Used for the claim that quality treatment spans levels of intensity chosen by assessment, and that behavioral therapy, medication, and mutual-help support are evidence-based options — the criteria a reviewer matches the requested level of care against.. The reviewer is deciding whether the level requested matches the assessed severity, usually against standardized criteria such as the ASAM framework.

That is why the clinical assessment is the center of gravity in any review. A peer-to-peer or an appeal that speaks directly to the criteria — naming the dimensions of severity the assessment actually found — is far more persuasive than a general plea that treatment is needed. The level-of-care matching question is the whole game, and the documented assessment is the evidence for it.

How a program's utilization-review team helps

Most treatment programs have staff whose job is exactly this, and using them is one of the biggest advantages you have. A treatment center's utilization-review team — sometimes called the insurance liaison — handles verification of benefits, submits prior authorizations, takes the concurrent-review calls, and represents your case on the peer-to-peer. They know the plan's criteria and the deadlines, because they do this every day.

Accreditation is one signal that a program takes this infrastructure seriously. CARF, an independent accreditor of behavioral-health and substance-use programs, uses peer surveyors to review programs against published standards, with a top decision of Three-Year Accreditation 4Ref 4CARF International (2024).Behavioral Health Accreditation.Used for the claim that CARF is an independent accreditor of behavioral-health and substance-use programs using peer surveyors against published standards, with a top decision of Three-Year Accreditation.. It is not a guarantee, but an accredited program is more likely to have the utilization-review staffing that keeps care authorized. When a denial looms, asking the program's utilization-review team to request the peer-to-peer and to prepare for appealing a coverage denial is usually the right first move.

Common questions

The peer is a physician working for your insurer — often the plan's medical director or a contracted reviewer — not a doctor who has examined you. The term means a fellow physician, someone qualified to discuss the clinical case with your treating clinician. Their role is to judge your case against the plan's medical-necessity criteria, which is why the treating clinician's specific clinical detail carries so much weight on the call.

The treating clinician conducts the peer-to-peer, because it is a doctor-to-doctor clinical conversation. You or the treatment program's utilization-review team typically requests it once a denial is issued or looming. You can and should prompt your provider to ask for one quickly, since these calls are often offered on very short windows and a missed window can push the case straight into a formal denial.

No. A peer-to-peer is an earlier, less formal step — a live call to try to resolve a denial before it becomes final. A formal appeal is the written process that follows if the denial stands, with internal and then external review stages. The peer-to-peer is faster and often successful, which is why it is usually worth pursuing before filing the written appeal.

The denial becomes formal, and you move to the appeal process: first an internal appeal decided by the insurer, then, if that fails, an independent external review whose decision the plan must honor. Parity law can strengthen the appeal if the plan's review of addiction care was stricter than its review of comparable medical care. A failed peer-to-peer is a step in the process, not the end of it.

Yes, through concurrent review, an insurer can decide that continued care is no longer justified and stop authorizing days mid-treatment. But that decision triggers rights: you can request a peer-to-peer, ask for the criteria applied, and appeal. Parity law limits how aggressively a plan can review addiction care compared with medical care, so a stay cut short is a decision worth contesting rather than accepting.

Substance use & recovery
How Insurers Use the ASAM Criteria to Decide
Substance use & recovery
Writing a Medical Necessity Appeal That Holds Up
Substance use & recovery
When Your Insurer Wants to End Treatment Early

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Do not let a review delay urgent care

—A withdrawal seizure, or confusion, sweating, fever, and a racing heart during alcohol or benzodiazepine withdrawal — signs of delirium tremens that need emergency care regardless of any review
—An opioid overdose: slow or stopped breathing, blue or gray lips and fingertips, or a person who cannot be woken
—A stay ended by concurrent review while the treating clinician still judges an interruption unsafe
—Thoughts of suicide during or after a coverage decision

Call 911 for a suspected overdose or a withdrawal seizure. For thoughts of suicide, call or text 988. Emergency care does not wait on utilization review, and a hospital must stabilize an emergency regardless of authorization. SAMHSA's National Helpline gives free, confidential referrals 24/7, and FindTreatment.gov lists licensed programs.

This article is general information about the insurance-review process, not legal or medical advice. Utilization-review rules, criteria, and deadlines vary by insurer and by state. Decisions about care should be made with a licensed clinician, and questions about a specific review or denial are best directed to the plan, the treating provider, and, where needed, a state insurance regulator.

References

1.Centers for Medicare & Medicaid Services (2024). Mental Health Parity and Addiction Equity Act (MHPAEA). Centers for Medicare & Medicaid Services (CMS). link ✓Used for the claim that MHPAEA generally bars plans covering mental-health/substance-use benefits from imposing more restrictive treatment limits — including utilization-management rules like prior authorization and concurrent review — than for comparable medical care.
2.Centers for Medicare & Medicaid Services / Medicaid.gov (2024). Parity — Behavioral Health Services. Medicaid.gov. linkUsed for the claim that parity requirements apply within Medicaid and CHIP for mental-health and substance-use benefits, extending the same principle to public coverage.
3.National Institute on Alcohol Abuse and Alcoholism (2024). Types of Alcohol Treatment — Alcohol Treatment Navigator. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. link ✓Used for the claim that quality treatment spans levels of intensity chosen by assessment, and that behavioral therapy, medication, and mutual-help support are evidence-based options — the criteria a reviewer matches the requested level of care against.
4.CARF International (2024). Behavioral Health Accreditation. CARF International. link ✓Used for the claim that CARF is an independent accreditor of behavioral-health and substance-use programs using peer surveyors against published standards, with a top decision of Three-Year Accreditation.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library